ALISON DASILVA: Open Payments
NPI 1427638089 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 10 payments from 8 companies in 2025. Trend: 2023 $338 · 2024 $275 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Edwards Lifesciences Corporation | 1 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Boston Scientific Corporation | 1 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, WaveWriter Alpha Prime 16, TRINTELLIX, ZENPEP, GVOKE HYPOPEN, KEVEYIS, AIRSUPRA, REXULTI.
Industry payments across CO — which companies pay providers there.
